Structure of PP2
CAS No.: 172889-27-9
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
PP2 is a reversible, ATP-competitive inhibitor of Src family kinases with IC50 values of 4 nM for Lck and 5 nM for Fyn.
Synonyms: PP2
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 172889-27-9 |
Formula : | C15H16ClN5 |
M.W : | 301.77 |
SMILES Code : | CC(C)(C)N1N=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1 |
Synonyms : |
PP2
|
MDL No. : | MFCD01568210 |
InChI Key : | PBBRWFOVCUAONR-UHFFFAOYSA-N |
Pubchem ID : | 4878 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
NB4 cells | 10 μM | 48 h | PP2 accelerated ATRA-induced G1/0 arrest and differentiation marker expression. | PMC3310950 |
HL-60 cells | 10 μM | 48 h | PP2 accelerated ATRA-induced G1/0 arrest and differentiation marker expression. | PMC3310950 |
Vascular smooth muscle cells (VSMC) | 10 μM | 5 min | PP2 inhibited Ang II-induced c-Src phosphorylation, indicating the role of PP2 in inhibiting c-Src activation. | PMC8953456 |
Rat mesenteric arteries | 10 μM | 15 min | To investigate the effect of PP2 on SPC-induced potentiation of vasoconstriction. The results showed that PP2 strongly suppressed SPC-induced potentiation of depolarization-induced contraction | PMC4362402 |
SW620 human colon cancer cells | 10 μM | PP2 inhibited the phosphorylation of c-Src, while PP3 had no such effect. | PMC5648044 | |
COS-7 cells | 10 µM | 2 h | PP2 inhibited Netrin-1-induced Rac1 activation, indicating the role of Src family kinases in Netrin-1 signaling. | PMC2172574 |
N1E-115 mouse neuroblastoma cells | 10 µM | 2 h | PP2 inhibited Netrin-1-induced tyrosine phosphorylation of DCC, indicating the role of Src family kinases in DCC phosphorylation. | PMC2172574 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Mice | NOX5 transgenic mice | Not specified | 10 µmol/L | Not specified | PP2 reduced the vascular contractile responses in NOX5 transgenic mice, indicating the role of PP2 in inhibiting c-Src-mediated vascular contraction. | PMC8953456 |
C57BL/6 mice | Μ+/- mice | Intraperitoneal injection | 5 mg/Kg | Once daily for 5 days | PP2 attenuated morphine tolerance, while PP3 had no such effect. | PMC5648044 |
Rat | Embryonic spinal commissural neurons | In vitro culture | 10 µM | 2 hours pretreatment, 10 minutes Netrin-1 stimulation | PP2 inhibited Netrin-1-induced tyrosine phosphorylation of DCC and axon outgrowth, indicating the critical role of Src family kinases in Netrin-1 signaling. | PMC2172574 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01434472 | Post-Transplant Lymphoprolifer... More >>ative Disorder Recurrent Adult Diffuse Large Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Burkitt Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << | Phase 2 | Recruiting | September 24, 2022 | United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal 206-288-2037 agopal@u.washington.edu Principal Investigator: Ajay K. Gopal Less << |
NCT00438880 | Adult Non-Hodgkin Lymphoma ... More >> Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Nodal Marginal Zone Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Less << | Phase 1 Phase 2 | Completed | - | United States, Iowa ... More >> University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
NCT00119392 | B-cell Chronic Lymphocytic Leu... More >>kemia Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << | Phase 2 | Completed | - | United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
NCT00577278 | Graft Versus Host Disease ... More >> Leukemia Lymphoma Less << | Phase 2 | Active, not recruiting | March 2019 | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less << |
NCT00119392 | - | Completed | - | - | |
NCT00695409 | - | Completed | - | - | |
NCT02366663 | Recurrent Diffuse Large B-Cell... More >> Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << | Phase 3 | Terminated(Withdrawal of spons... More >>or support) Less << | - | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT00438880 | - | Completed | - | - | |
NCT02366663 | - | Terminated(Withdrawal of spons... More >>or support) Less << | - | - | |
NCT00797797 | Fibromyalgia | Phase 3 | Completed | - | - |
NCT02320292 | Stage I Grade 1 Follicular Lym... More >>phoma Stage I Grade 2 Follicular Lymphoma Stage II Grade 1 Contiguous Follicular Lymphoma Stage II Grade 1 Non-Contiguous Follicular Lymphoma Stage II Grade 2 Contiguous Follicular Lymphoma Stage II Grade 2 Non-Contiguous Follicular Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Less << | Phase 3 | Recruiting | January 2026 | United States, Iowa ... More >> University of Iowa/Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: George J. Weiner 800-237-1225 george-weiner@uiowa.edu Principal Investigator: George J. Weiner United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Thomas E. Witzig Less << |
NCT00797797 | - | Completed | - | - | |
NCT00038623 | Lymphoma, Mantle-Cell | Phase 2 | Completed | - | United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT00695409 | Lymphoma | Phase 2 | Completed | - | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less << |
NCT01686165 | Anaplastic Large Cell Lymphoma... More >> Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma Less << | Phase 2 | Completed | - | United States, Arizona ... More >> University of Arizona Cancer Center Tucson, Arizona, United States, 85724-5024 Less << |
NCT02315287 | Type 2 Diabetes | Phase 4 | Recruiting | December 2018 | Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD 82-31-787-7035 limsoo@snu.ac.kr Contact: Eu Jeong Ku, MD 82-31-787-6232 eujeong.ku@gmail.com Principal Investigator: Soo Lim, MD, PHD Less << |
NCT01686165 | - | Completed | - | - | |
NCT02338921 | Type 2 Diabetes | Phase 4 | Recruiting | December 2018 | Korea, Republic of ... More >> Soo Lim Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Dong Hwa Lee, MD Less << |
NCT00591630 | Diffuse Large Cell Lymphoma ... More >> Lymphoma Less << | Phase 2 | Active, not recruiting | November 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT01973062 | Primary Central Nervous System... More >> Non-Hodgkin Lymphoma Less << | Phase 2 | Terminated(Funding Unavailable... More >>) Less << | - | United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less << |
NCT01973062 | - | Terminated(Funding Unavailable... More >>) Less << | - | - | |
NCT03233672 | Prostate Cancer | Not Applicable | Completed | - | - |
NCT00493467 | Lymphoma | Phase 2 | Completed | - | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT02036554 | Kidney; Complications, Allogra... More >>ft Less << | Phase 4 | Unknown | December 2015 | Korea, Republic of ... More >> division of nephrology;Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Chul Woo Yang 82-2-2258-6851 yangch@catholic.ac.kr Less << |
NCT00387023 | Non-Hodgkin's Lymphoma ... More >> Lymphoma Less << | Not Applicable | Completed | - | United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT00064246 | Post-transplant Lymphoprolifer... More >>ative Disorder Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Waldenstr?m Macroglobulinemia Less << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... More >> AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States, 20850 Less << |
NCT00477815 | Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << | Phase 1 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
NCT00036855 | AIDS-related Peripheral/System... More >>ic Lymphoma AIDS-related Primary CNS Lymphoma Post-transplant Lymphoproliferative Disorder Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Less << | Phase 1 | Terminated(Administratively co... More >>mplete.) Less << | - | United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less << |
NCT00290511 | Lymphoma | Phase 2 | Active, not recruiting | August 24, 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT00387023 | - | Completed | - | - | |
NCT03077360 | Diabetes Mellitus, Type 2 ... More >> Pre-diabetes Obesity Less << | Not Applicable | Recruiting | January 31, 2021 | United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Simona Zarini, PhD 303-724-3968 Simona.Zarini@ucdenver.edu Less << |
NCT02185339 | Laparoscopic Renal Surgery ... More >> Laparoscopy Muscle Relaxation Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less << |
NCT00031642 | Lymphoma | Phase 1 Phase 2 | Completed | - | United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 Less << |
NCT02407626 | Myocardial Ischemia | Not Applicable | Terminated(Very low patient re... More >>cruitment, changed insurance requirements) Less << | - | Switzerland ... More >> Triemli City Hospital Zurich, Switzerland, 8063 Less << |
NCT00058292 | Lymphoma | Phase 1 | Completed | - | United States, Illinois ... More >> Hematology-Oncology Associates of Illinois Chicago, Illinois, United States, 60611-2998 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less << |
NCT01041144 | Type 2 Diabetes ... More >> Lifestyle Intervention Glucose Control Internet Communication Less << | Not Applicable | Completed | - | Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-041 Less << |
NCT00017381 | Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Waldenstr?m Macroglobulinemia Less << | Early Phase 1 | Completed | - | United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less << |
NCT00437554 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | Korea, Republic of ... More >> Handok Seoul, Korea, Republic of Less << |
NCT00012298 | Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << | Phase 1 Phase 2 | Terminated(Trial completed pre... More >>maturely.) Less << | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
NCT02185339 | - | Completed | - | - | |
NCT00807365 | - | Terminated(PI left JHU) | - | - | |
NCT00807365 | Elderly | Phase 2 | Terminated(PI left JHU) | - | United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less << |
NCT00012298 | - | Terminated(Trial completed pre... More >>maturely.) Less << | - | - | |
NCT01047605 | Healthy | Phase 1 | Completed | - | Germany ... More >> Neurocode AG Wetzlar, Germany, D-35578 Less << |
NCT00005592 | Lymphoma | Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 United States, District of Columbia Lombardi Cancer Center Washington, District of Columbia, United States, 20007 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.31mL 0.66mL 0.33mL |
16.57mL 3.31mL 1.66mL |
33.14mL 6.63mL 3.31mL |